Difference between revisions of "WSI21-21-Case-3"

From MGH Learn Pathology
(Automatic edit to upgrade to new templates)
(Updating subject, access, and performer)
Line 17: Line 17:
 
|reasonCode=Pelvic mass; TRT 11:55
 
|reasonCode=Pelvic mass; TRT 11:55
 
|subject=MGH
 
|subject=MGH
|performer=Gn014
+
|performer=GN014
 
|authoredOn=December 14, 2021 09:59:40 PM
 
|authoredOn=December 14, 2021 09:59:40 PM
 
|requester=Aja51
 
|requester=Aja51
 
|sequence=3
 
|sequence=3
 +
|access=private
 
}}
 
}}
 
{{Media
 
{{Media

Revision as of 15:06, June 21, 2022

WSI21-21-Case-3
Pelvic mass; TRT 11:55
A. LEFT PELVIC MASS:

EWING SARCOMA Immunohistochemistry performed at the outside institution and reviewed at MGH. Positive – CD99, NKX2.2, FLI1 Negative – WT1 Per outside hospital report, keratin AE1/AE3, CD45, chromogranin, synaptophysin, myogenin, melanoma cocktail and are reported to be negative.

NGS showed EWR1/FLI1 gene fusion.
December 31, 1969 7:00:00 PM